Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lunai Bioworks Inc. - Common Stock (NQ:RENB)

1.420 UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Lunai Bioworks Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Alarming Data Highlights Gaps in Treating People with Chronic HBV
Via Investor Brand Network
Biotech Firms Register Successes in Quest for Better Pancreatic Cancer Treatments
Via Investor Brand Network
Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Provides Insights on Definitive Agreement to Combine with GEDi Cube to Transform Medicine
Via Investor Brand Network
Topics Artificial Intelligence
Scientists Find Potential to Reverse Prostate Cancer Treatment Resistance
Via Investor Brand Network
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Participating in Webinar Focused on Future Health Tech
Via Investor Brand Network
Everything You Need to Know About Nonreactive Hep B Screening Results
Via Investor Brand Network
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Appoints Intel Capital Cofounder to Board
Via Investor Brand Network
News headline image
Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors
From Renovaro Biosciences Inc.
Via GlobeNewswire
Patients with Metastatic Solid Tumors Have Better Outcomes After Prophylactic Radiation, Study Finds
Via Investor Brand Network
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Announces Strategic Board Appointments of Two Finance Industry Experts
Via Investor Brand Network
News headline image
Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors
From Renovaro Biosciences Inc.
Via GlobeNewswire
News headline image
RENOVARO BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Renovaro Biosciences Inc. - RENB
From Kahn Swick & Foti, LLC
Via Business Wire
New Prediction Model Could Slash Unnecessary Pancreatic Cancer Biopsies
Via Investor Brand Network
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Releases Shareholder Letter Regarding Agreement to Combine with Leading AI Company
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD
AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine 
From Renovaro Biosciences Inc.
Via GlobeNewswire
News headline image
AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine
From Renovaro Biosciences Inc.
Via GlobeNewswire
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Enters Definitive Agreement to Combine with Leading AI Tech GEDi Cube
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
RENB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Renovaro Biosciences Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine
From Renovaro Biosciences Inc.
Via GlobeNewswire
Eliminating Barriers Surrounding Solid Tumors Allows T Cells to Kill Cancerous Cells
Via Investor Brand Network
Why Colon Cancer Is Largely Unresponsive to Immunotherapy
Via Investor Brand Network
BioMedNewsBreaks – IBN’s BioMedWire Highlights NanoVibronix Inc.’s (NASDAQ: NAOV) $5M Private Placement
Via Investor Brand Network
Renovaro BioSciences Inc. (NASDAQ: RENB) Targets Pancreatic Cancer Solution Through Work With GEDI Cube AI Platform, NVIDIA Resources
Via Investor Brand Network
Topics Artificial Intelligence
UI Research Suggests Immune System Can Be Trained to Combat Solid Tumors
Via Investor Brand Network
BioMedNewsBreaks — Why Renovaro BioSciences Inc. (NASDAQ: RENB) Is ‘One to Watch’
Via Investor Brand Network
Stack Foundation Gives UC San Diego $5M Gift to Advance Gene Therapy
Via Investor Brand Network
Tracking Off-Label Cancer Treatment Could Ease Future Trials, Remedies
Via Investor Brand Network
UC San Diego Researchers Suggest Stem Cell Transplantation Could Treat Alzheimer’s
Via Investor Brand Network
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Congratulates GEDiCube on New Joint Effort Clinical Trials
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Renovaro BioSciences Welcomes GEDiCube Announcement of New Joint Effort
From Renovaro Biosciences Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.